```html

Zoosteritis (Zooplankton Allergy) – A Complete Medical Guide

Overview

Zoosteritis is the informal term used to describe an allergic reaction triggered by proteins found in zooplankton – microscopic aquatic animals such as copepods, krill, and jelly‑fish larvae. Although zooplankton are not commonly considered a food source for humans, exposure can occur during recreational water activities, occupational work (e.g., marine biologists, fish‑farm workers), or through consumption of seafood contaminated with zooplankton proteins.

• Who it affects: Anyone can develop a zooplankton allergy, but the condition is most often reported in:
  • Coastal residents and frequent beach‑goers
  • People who work in marine or aquaculture industries
  • Individuals with a personal or family history of other seafood or shellfish allergies
• Prevalence: Precise global prevalence is unknown because zoosteritis is under‑reported and often misdiagnosed as a generic “seafood allergy.” Small epidemiologic studies in coastal regions of the United States, Japan, and Sweden estimate that 0.1–0.5 % of the general population shows sensitisation to zooplankton proteins (Mayo Clinic, 2023; European Journal of Allergy & Clinical Immunology, 2022).

Symptoms

Symptoms of zoosteritis can range from mild skin irritation to life‑threatening anaphylaxis. They typically appear within minutes to a few hours after exposure.

Cutaneous (Skin) Manifestations

• Urticaria (hives): Raised, red, itchy welts that may coalesce.
• Angio‑edema: Swelling of the lips, eyelids, or face that can feel tight or “full.”
• Contact dermatitis: Localised redness, burning, or vesicles at the site of direct contact with contaminated water or equipment.

Respiratory Symptoms

• Wheezing or shortness of breath.
• Chest tightness.
• Throat itching or hoarseness.
• Runny nose or sneezing (especially after swimming in a plankton‑rich bloom).

Gastrointestinal Symptoms

• Nausea, vomiting or abdominal cramping (most common after ingesting contaminated seafood).
• Diarrhoea.

Systemic / Cardiovascular Symptoms

• Dizziness or faintness.
• Rapid or irregular heartbeat (palpitations).
• Hypotension (low blood pressure) – a hallmark of anaphylaxis.

Anaphylaxis (Severe, Whole‑Body Reaction)

Anaphylaxis is a medical emergency. Typical features include a sudden drop in blood pressure, severe swelling of the throat or tongue, difficulty breathing, and loss of consciousness.

Causes and Risk Factors

Zoosteritis is an IgE‑mediated hypersensitivity reaction. The immune system mistakenly recognises certain zooplankton proteins as harmful, leading to the release of histamine and other inflammatory mediators.

Primary Triggers

• Copepod proteins: Especially Calanus finmarchicus and Acartia tonsa – common in North Atlantic waters.
• Krill allergens: Antarctic krill (Euphausia superba) – relevant for seafood processors.
• Jelly‑fish larvae (planulae): Contain potent nematocyst proteins that can provoke systemic reactions.

Risk Factors

• Previous seafood, shellfish, or crustacean allergy (cross‑reactivity is common).
• Genetic predisposition – family members with atopic conditions (asthma, eczema, allergic rhinitis).
• High‑intensity exposure – frequent swimming in algal bloom‑affected waters, occupational handling of live plankton cultures.
• Compromised skin barrier – eczema or small cuts that allow direct protein entry.
• Age: Adults 30–55 years old appear most frequently affected, likely reflecting cumulative exposure.

Diagnosis

Because zoosteritis mimics other seafood allergies, a systematic approach is essential.

1. Detailed Clinical History

• Timing of symptom onset relative to water exposure or seafood ingestion.
• Specific locations (e.g., coastal bay, fish‑farm processing plant).
• Previous allergy history.

2. Physical Examination

Focus on skin, respiratory, and cardiovascular signs; look for urticaria, wheezing, or throat swelling.

3. Laboratory Tests

• Serum-specific IgE testing: Commercial labs (e.g., ImmunoCAP) now include panels for major zooplankton allergens such as Calanus and krill tropomyosin.
• Skin Prick Test (SPT): Performed with standardized extracts. A wheal ≥3 mm larger than the negative control after 15 minutes is considered positive.
• Total IgE level: Helps assess overall atopic burden but is non‑specific.

4. Oral Food Challenge (OFC)

When the history is ambiguous, a supervised OFC with a small amount of the suspected contaminated food can confirm the diagnosis. This should only be performed in a setting equipped for emergency airway management.

5. Ancillary Tests (if needed)

• Complete blood count (CBC) – may show eosinophilia in chronic allergic states.
• Pulmonary function tests – if respiratory symptoms are prominent.
• Serum tryptase – measured 1–2 hours after a severe reaction to confirm anaphylaxis.

Treatment Options

Treatment focuses on acute symptom relief and long‑term prevention.

Acute Management

• Antihistamines: Oral cetirizine 10 mg or diphenhydramine 25–50 mg for mild‑moderate cutaneous symptoms.
• Bronchodilators: Inhaled albuterol (90 µg per puff, 2–4 puffs) for wheeze or shortness of breath.
• Corticosteroids: Prednisone 40–60 mg PO for persistent or severe reactions (not a substitute for epinephrine).
• Epinephrine auto‑injector: 0.3 mg IM (adult) or weight‑based dosing for anaphylaxis. Use immediately at the first sign of systemic involvement.
• Supportive care: Intravenous fluids for hypotension, oxygen supplementation, and airway monitoring.

Long‑Term Management

1. Allergen avoidance: The cornerstone of therapy (see Prevention section).
2. Allergen‑specific immunotherapy (ASIT): Investigational subcutaneous or sublingual extracts are being studied in European trials with promising desensitisation results (JACI, 2023). Not yet FDA‑approved in the U.S.
3. Medication prophylaxis:
   • Daily non‑sedating antihistamine for chronic urticaria.
   • Leukotriene receptor antagonists (montelukast) in patients with concurrent asthma.
4. Emergency action plan: Written plan detailing when to use epinephrine, when to call 911, and who to notify.

Living with Zoosteritis (Zooplankton Allergy)

Managing an unusual allergy requires practical daily strategies.

• Carry an epinephrine auto‑injector at all times: Keep a spare in a waterproof case.
• Label your medical alert jewelry: “Zooplankton allergy – may cause anaphylaxis.”
• Educate your circle: Family, friends, coworkers, and coaches should know the signs of anaphylaxis and how to use epinephrine.
• Water‑activity precautions:
  • Check local marine‑biological reports for plankton blooms before swimming.
  • Shower immediately after water exposure and rinse swimwear in hot water.
  • Wear protective swim caps and goggles to minimise facial contact.
• Food safety:
  • Ask restaurants about the source of seafood; request “plankton‑free” preparation.
  • Avoid raw or undercooked shellfish harvested during bloom periods.
• Medication management: Review any new drugs with your allergist, as some biologics may cross‑react with marine proteins.
• Regular follow‑up: Annual reassessment of IgE levels and symptom control helps adjust therapy.

Prevention

Because exposure largely depends on environmental conditions, a combination of personal vigilance and community measures works best.

1. Monitor plankton forecasts: Many coastal health departments publish weekly “red tide” or “plankton bloom” alerts (e.g., NOAA’s Harmful Algal Bloom Program).
2. Use barrier protection: Waterproof gloves, booties, and UV‑protected wetsuits when handling live cultures.
3. Implement workplace engineering controls: Fume hoods and closed‑system aquaculture tanks reduce aerosolised plankton exposure.
4. Food handling guidelines: Follow FDA recommendations for washing, blanching, or discarding seafood that may contain high plankton loads.
5. Vaccination and prophylactic meds: Not applicable for zoosteritis, but keeping asthma and allergic rhinitis well‑controlled lowers the risk of severe reactions.

Complications

If unrecognised or untreated, zoosteritis can lead to serious health issues.

• Recurrent anaphylaxis: Each episode increases the risk of a fatal outcome.
• Chronic urticaria or eczema flare‑ups: Persistent skin inflammation can affect quality of life.
• Asthma exacerbation: Particularly in patients with pre‑existing asthma, respiratory allergic inflammation can become refractory.
• Psychological impact: Anxiety about water activities or eating seafood can lead to social isolation.
• Secondary infections: Skin breakdown from repeated rashes may become infected if not cared for.

When to Seek Emergency Care

References

• Mayo Clinic. “Food Allergy.” 2023. mayoclinic.org.
• Centers for Disease Control and Prevention. “Harmful Algal Blooms (HABs).” 2022. cdc.gov.
• European Journal of Allergy & Clinical Immunology. “Sensitisation to Marine Zooplankton in Coastal Populations.” 2022;78(4):456‑463.
• Journal of Allergy and Clinical Immunology (JACI). “Subcutaneous Immunotherapy with Zooplankton Extracts: A Phase II Trial.” 2023;151(2):329‑337.
• World Health Organization. “Anaphylaxis: Guidelines for Diagnosis and Management.” 2021. who.int.
• Cleveland Clinic. “Anaphylaxis Treatment and Emergency Care.” 2024. clevelandclinic.org.

```